HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.

Abstract: Objective: To investigate the plausibility of a mathematical model of the ballistocardiogram (BCG) called the “BCG-blood pressure (BP) model” developed in our prior work. Methods: We ...

Edwards Lifesciences said Friday it has dropped plans to acquire JenaValve Technology after a U.S. district court granted the Federal Trade Commission’s motion for an injunction blocking the ...

Edwards Lifesciences (NYSE: EW) + announced that it will not acquire JenaValve following a legal win by the U.S. Federal Trade Commission (FTC). Yesterday, Jan. 9, a federal judge in D.C. granted the ...

The following are the top rated Health Care stocks according to Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that ...